Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis

1.1kCitations
Citations of this article
713Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The tumour-suppressor phosphatase with tensin homology (PTEN) is the most important negative regulator of the cell-survival signalling pathway initiated by phosphatidylinositol 3-kinase (PI3K). Although PTEN is mutated or deleted in many tumours, deregulation of the PI3K-PTEN network also occurs through other mechanisms. Crosstalk between the PI3K pathways and other tumorigenic signalling pathways, such as those that involve Ras, p53, TOR (target of rapamycin) or DJ1, can contribute to this deregulation. How does the PI3K pathway integrate signals from numerous sources, and how can this information be used in the rational design of cancer therapies? © 2006 Nature Publishing Group.

Cite

CITATION STYLE

APA

Cully, M., You, H., Levine, A. J., & Mak, T. W. (2006, March). Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature Reviews Cancer. https://doi.org/10.1038/nrc1819

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free